Year |
Citation |
Score |
2019 |
Lepage ML, Kuo HT, Roxin A, Huh S, Zhang Z, Kandasamy RL, Merkens H, Kumlin J, Limoges A, Zeisler SK, Benard F, Lin KS, Perrin D. Toward 18F-Labeled Theranostics: A Single Agent that can be Labeled with 18F, 64Cu, or 177Lu. Chembiochem : a European Journal of Chemical Biology. PMID 31621172 DOI: 10.1002/Cbic.201900632 |
0.327 |
|
2019 |
Roxin A, Zhang C, Huh S, Lepage ML, Zhang Z, Lin KS, Bénard F, Perrin DM. A Metal-Free DOTA-Conjugated 18F-Labeled Radiotracer: [18F]DOTA-AMBF3-LLP2A for Imaging VLA-4 Over-Expression in Murine Melanoma with Improved Tumor Uptake and Greatly Enhanced Renal Clearance. Bioconjugate Chemistry. PMID 30896929 DOI: 10.1021/Acs.Bioconjchem.9B00146 |
0.337 |
|
2019 |
Kuo HT, Lepage M, Lin KS, Pan J, Zhang Z, Liu Z, Pryyma A, Zhang C, Merkens H, Roxin A, Perrin D, Benard F. One-step F-labeling and preclinical evaluation of prostate specific membrane antigen trifluoroborate probes for cancer imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30737299 DOI: 10.2967/Jnumed.118.216598 |
0.333 |
|
2018 |
Roxin Á, Zhang C, Huh S, Lepage ML, Zhang Z, Lin KS, Bénard F, Perrin DM. Preliminary evaluation ofF-labeled LLP2A-trifluoroborate conjugates as VLA-4 (αβintegrin) specific radiotracers for PET imaging of melanoma. Nuclear Medicine and Biology. 61: 11-20. PMID 29597141 DOI: 10.1016/J.Nucmedbio.2018.02.005 |
0.319 |
|
2016 |
Walker D, Li Y, Roxin Á, Schaffer P, Adam MJ, Perrin DM. Facile synthesis and (18)F-radiolabeling of α4β1-specific LLP2A-aryltrifluoroborate peptidomimetic conjugates. Bioorganic & Medicinal Chemistry Letters. PMID 27623550 DOI: 10.1016/J.Bmcl.2016.08.011 |
0.358 |
|
2015 |
Farhadi A, Roxin Á, Wilson BC, Zheng G. Nano-enabled SERS reporting photosensitizers. Theranostics. 5: 469-76. PMID 25767614 DOI: 10.7150/Thno.10694 |
0.467 |
|
2014 |
Ng KK, Shakiba M, Huynh E, Weersink RA, Roxin Á, Wilson BC, Zheng G. Stimuli-responsive photoacoustic nanoswitch for in vivo sensing applications. Acs Nano. 8: 8363-73. PMID 25046406 DOI: 10.1021/Nn502858B |
0.532 |
|
2014 |
Luby BM, Farhadi A, Shakiba M, Charron DM, Roxin A, Zheng G. Research Highlights: highlights from the latest articles in nanomedicine. Nanomedicine (London, England). 9: 385-8. PMID 24787437 DOI: 10.2217/Nnm.13.216 |
0.333 |
|
2014 |
Roxin Ã, Chen J, Paton AS, Bender TP, Zheng G. Modulation of reactive oxygen species photogeneration of bacteriopheophorbide a derivatives by exocyclic E-ring opening and charge modifications. Journal of Medicinal Chemistry. 57: 223-37. PMID 24328124 DOI: 10.1021/Jm401538H |
0.392 |
|
2014 |
Roxin A, MacDonald TD, Zheng G. Synthesis and characterization of a new natural product analog, 13 2-173-bacteriochlorophyllone a Journal of Porphyrins and Phthalocyanines. 18: 188-199. DOI: 10.1142/S1088424613501058 |
0.401 |
|
2012 |
Roxin Ã, Zheng G. Flexible or fixed: a comparative review of linear and cyclic cancer-targeting peptides. Future Medicinal Chemistry. 4: 1601-18. PMID 22917248 DOI: 10.4155/Fmc.12.75 |
0.406 |
|
2012 |
Roxin Ã, Chen J, Scully CC, Rotstein BH, Yudin AK, Zheng G. Conformational modulation of in vitro activity of cyclic RGD peptides via aziridine aldehyde-driven macrocyclization chemistry. Bioconjugate Chemistry. 23: 1387-95. PMID 22709546 DOI: 10.1021/Bc300239A |
0.45 |
|
2011 |
Lovell JF, Roxin A, Ng KK, Qi Q, McMullen JD, DaCosta RS, Zheng G. Porphyrin-cross-linked hydrogel for fluorescence-guided monitoring and surgical resection. Biomacromolecules. 12: 3115-8. PMID 21777008 DOI: 10.1021/Bm200784S |
0.553 |
|
Show low-probability matches. |